Identification of Potential Pathway Mediation Targets in Toll-like Receptor Signaling
暂无分享,去创建一个
Bernhard O. Palsson | Ines Thiele | Neema Jamshidi | Fan Li | B. Palsson | N. Jamshidi | I. Thiele | Fan Li
[1] W. Kolch,et al. Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. , 2001, Molecular and cellular biology.
[2] Ronan M. T. Fleming,et al. Genome-Scale Reconstruction of Escherichia coli's Transcriptional and Translational Machinery: A Knowledge Base, Its Mathematical Formulation, and Its Functional Characterization , 2009, PLoS Comput. Biol..
[3] Harald Stenmark,et al. Role of Rab5 in the Recruitment of hVps34/p150 to the Early Endosome , 2002, Traffic.
[4] H. Qian,et al. Energy balance for analysis of complex metabolic networks. , 2002, Biophysical journal.
[5] Michael Gale,et al. Toll-Like Receptor 3 Has a Protective Role against West Nile Virus Infection , 2008, Journal of Virology.
[6] B. Palsson. Systems Biology: Properties of Reconstructed Networks , 2006 .
[7] Robert Urbanczik,et al. An improved algorithm for stoichiometric network analysis: theory and applications , 2005, Bioinform..
[8] Nan Xiao,et al. Integrating metabolic, transcriptional regulatory and signal transduction models in Escherichia coli , 2008, Bioinform..
[9] F. Liew,et al. Negative regulation of Toll-like receptor-mediated immune responses , 2005, Nature Reviews Immunology.
[10] F. Re,et al. Monomeric Recombinant MD-2 Binds Toll-like Receptor 4 Tightly and Confers Lipopolysaccharide Responsiveness* , 2002, The Journal of Biological Chemistry.
[11] Bernhard O. Palsson,et al. Estimation of the number of extreme pathways for metabolic networks , 2007, BMC Bioinformatics.
[12] B. Beutler,et al. Inferences, questions and possibilities in Toll-like receptor signalling , 2004, Nature.
[13] M Locati,et al. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. , 2001, Trends in immunology.
[14] B. Palsson,et al. Candidate Metabolic Network States in Human Mitochondria , 2005, Journal of Biological Chemistry.
[15] Gregory D. Longmore,et al. The LIM Protein Ajuba Influences Interleukin-1-Induced NF-κB Activation by Affecting the Assembly and Activity of the Protein Kinase Cζ/p62/TRAF6 Signaling Complex , 2005, Molecular and Cellular Biology.
[16] Eun Jeoung Lee,et al. Inhibition of mitogen-activated kinase kinase kinase 3 activity through phosphorylation by the serum- and glucocorticoid-induced kinase 1. , 2003, Journal of biochemistry.
[17] Hideo Negishi,et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses , 2005, Nature.
[18] K. Wirtz,et al. Phosphatidic acid is a specific activator of phosphatidylinositol-4-phosphate kinase. , 1992, The Journal of biological chemistry.
[19] S. Akira,et al. Toll-like receptor function and signaling. , 2006, The Journal of allergy and clinical immunology.
[20] Adam M. Feist,et al. Reconstruction of biochemical networks in microorganisms , 2009, Nature Reviews Microbiology.
[21] C. Dinarello,et al. Biologic basis for interleukin-1 in disease. , 1996, Blood.
[22] Kenneth J. Kauffman,et al. Advances in flux balance analysis. , 2003, Current opinion in biotechnology.
[23] C. Coban,et al. Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6 , 2004, Nature Immunology.
[24] Jun Dong,et al. Understanding network concepts in modules , 2007, BMC Systems Biology.
[25] H. Kitano,et al. A comprehensive map of the toll-like receptor signaling network , 2006, Molecular systems biology.
[26] S. Akira,et al. TLR signaling. , 2006, Cell death and differentiation.
[27] W. Liao,et al. The IL-1 receptor accessory protein is essential for PI 3-kinase recruitment and activation. , 2004, Biochemical and biophysical research communications.
[28] Bernhard Ø Palsson,et al. Candidate states of Helicobacter pylori's genome-scale metabolic network upon application of "loop law" thermodynamic constraints. , 2006, Biophysical journal.
[29] R. Gazzinelli,et al. Role of TLRs/MyD88 in host resistance and pathogenesis during protozoan infection: lessons from malaria , 2008, Seminars in Immunopathology.
[30] Phillip T. Hawkins,et al. Translocation of PDK-1 to the plasma membrane is important in allowing PDK-1 to activate protein kinase B , 1998, Current Biology.
[31] B. Palsson,et al. Genome-scale models of microbial cells: evaluating the consequences of constraints , 2004, Nature Reviews Microbiology.
[32] Hla Y Win,et al. Atypical protein kinase C phosphorylates IKKalphabeta in transformed non-malignant and malignant prostate cell survival. , 2008, Cancer letters.
[33] Madhukar S. Dasika,et al. A computational framework for the topological analysis and targeted disruption of signal transduction networks. , 2006, Biophysical journal.
[34] An-Ping Zeng,et al. The Connectivity Structure, Giant Strong Component and Centrality of Metabolic Networks , 2003, Bioinform..
[35] H. Nakano,et al. The atypical PKC‐interacting protein p62 channels NF‐κB activation by the IL‐1–TRAF6 pathway , 2000, The EMBO journal.
[36] S. Akira,et al. Toll-like receptors. , 2003, Annual review of immunology.
[37] Matthew S. Hayden,et al. New regulators of NF-κB in inflammation , 2008, Nature Reviews Immunology.
[38] Ronan M. T. Fleming,et al. Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0 , 2007, Nature Protocols.
[39] P A Insel,et al. Protein kinase C isozymes and the regulation of diverse cell responses. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[40] Bernhard O. Palsson,et al. Matrix Formalism to Describe Functional States of Transcriptional Regulatory Systems , 2006, PLoS Comput. Biol..
[41] K. Griendling,et al. Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. , 2007, Trends in cardiovascular medicine.
[42] A. Iwasaki,et al. Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.
[43] Bernhard O. Palsson,et al. Bringing Genomes to Life: The Use of Genome-Scale In Silico Models , 2007 .
[44] Grazia Gallo,et al. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound , 2007, Journal of leukocyte biology.
[45] B. Palsson,et al. Expanded Metabolic Reconstruction of Helicobacter pylori (iIT341 GSM/GPR): an In Silico Genome-Scale Characterization of Single- and Double-Deletion Mutants , 2005, Journal of bacteriology.
[46] C. Elbim,et al. Phagocyte NADPH oxidase: a multicomponent enzyme essential for host defenses. , 2005, Archivum immunologiae et therapiae experimentalis.
[47] Uri Alon,et al. Input–output robustness in simple bacterial signaling systems , 2007, Proceedings of the National Academy of Sciences.
[48] B. Beutler,et al. TLR signaling pathways: opportunities for activation and blockade in pursuit of therapy. , 2006, Current pharmaceutical design.
[49] M. Sajan,et al. Insulin and PIP3 activate PKC-zeta by mechanisms that are both dependent and independent of phosphorylation of activation loop (T410) and autophosphorylation (T560) sites. , 2001, Biochemistry.
[50] Jason A. Papin,et al. The JAK-STAT signaling network in the human B-cell: an extreme signaling pathway analysis. , 2004, Biophysical journal.
[51] T. Taniguchi,et al. IRF family of transcription factors as regulators of host defense. , 2001, Annual review of immunology.
[52] Makoto Sawada,et al. Stimulus-dependent Regulation of the Phagocyte NADPH Oxidase by a VAV1, Rac1, and PAK1 Signaling Axis* , 2008, Journal of Biological Chemistry.
[53] Uri Alon,et al. An Introduction to Systems Biology , 2006 .
[54] F. Meyskens,et al. UC Irvine UC Irvine Previously Published Works Title Reactive oxygen species : a breath of life or death ? , 2007 .
[55] Erwin P. Gianchandani,et al. Dynamic Analysis of Integrated Signaling, Metabolic, and Regulatory Networks , 2008, PLoS Comput. Biol..
[56] B. Palsson,et al. Towards multidimensional genome annotation , 2006, Nature Reviews Genetics.
[57] T. Akazawa,et al. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3–mediated interferon-β induction , 2003, Nature Immunology.
[58] B. Palsson,et al. Metabolic Flux Balancing: Basic Concepts, Scientific and Practical Use , 1994, Bio/Technology.
[59] Ronan M. T. Fleming,et al. Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0 , 2007, Nature Protocols.
[60] A. Hall,et al. Rho GTPases and their effector proteins. , 2000, The Biochemical journal.
[61] Martin Braddock,et al. Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention , 2004, Nature Reviews Drug Discovery.
[62] A. Sher,et al. Cooperation of Toll-like receptor signals in innate immune defence , 2007, Nature Reviews Immunology.
[63] N. Perkins. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway , 2006, Oncogene.
[64] Monica L. Mo,et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.
[65] D. Boraschi,et al. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. , 1998, Journal of immunology.
[66] Ruslan Medzhitov,et al. Toll-like receptors and acquired immunity. , 2004, Seminars in immunology.
[67] Kyongbum Lee,et al. BIOINFORMATICS ORIGINAL PAPER doi:10.1093/bioinformatics/btm374 Systems biology Modular decomposition of metabolic reaction networks based on flux analysis and pathway projection , 2022 .
[68] Gerene M Denning,et al. Endotoxin, TLR4 signaling and vascular inflammation: potential therapeutic targets in cardiovascular disease. , 2006, Current pharmaceutical design.
[69] J Tuomilehto,et al. Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis , 2007, Annals of the rheumatic diseases.
[70] Guo-Ping Zhou,et al. Triggering the Interferon Antiviral Response Through an IKK-Related Pathway , 2003, Science.
[71] Bernhard O. Palsson,et al. Metabolic flux balance analysis and the in silico analysis of Escherichia coli K-12 gene deletions , 2000, BMC Bioinformatics.
[72] J. Banchereau,et al. Pyogenic Bacterial Infections in Humans with MyD88 Deficiency , 2003, Science.
[73] P. Tobias,et al. Toll-like receptors and atherosclerosis , 2006, Immunologic research.
[74] R. Maccioni,et al. Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease. , 2008, Archives of medical research.
[75] T. Muta,et al. Essential roles of CD14 and lipopolysaccharide-binding protein for activation of toll-like receptor (TLR)2 as well as TLR4 Reconstitution of TLR2- and TLR4-activation by distinguishable ligands in LPS preparations. , 2001, European journal of biochemistry.
[76] P. Hertzog,et al. Toll-like receptor signalling and the clinical benefits that lie within , 2007, Inflammation Research.
[77] H. Ichijo,et al. ASK Family Proteins in Stress Response and Disease , 2007, Molecular biotechnology.
[78] L. O’Neill,et al. How Toll-like receptors signal: what we know and what we don't know. , 2006, Current opinion in immunology.